NCT05166447View on ClinicalTrials.gov

Twenty-year Follow-up of the Inter99 Cohort

Enrolling by invitationOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

September 13, 2021

Primary Completion Date

September 1, 2024

Study Completion Date

December 1, 2028

Conditions
Coronary Heart DiseaseAcute Myocardial InfarctionCardiovascular DiseasesType 2 DiabetesObesityBirth Weight
Trial Locations (1)

2600

Center for Klinisk Forskning og Forebyggelse, Glostrup Municipality

All Listed Sponsors
collaborator

Steno Diabetes Center Copenhagen

OTHER

collaborator

The Novo Nordisk Foundation Center for Basic Metabolic Research

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

lead

Bispebjerg Hospital

OTHER